Literature DB >> 29246901

Evolutionary basis of HLA-DPB1 alleles affects acute GVHD in unrelated donor stem cell transplantation.

Satoko Morishima1,2, Takashi Shiina3, Shingo Suzuki3, Seishi Ogawa4, Aiko Sato-Otsubo4, Koichi Kashiwase5, Fumihiro Azuma5, Toshio Yabe5, Masahiro Satake6, Shunichi Kato7, Yoshihisa Kodera8, Takehiko Sasazuki9, Yasuo Morishima8,10.   

Abstract

HLA-DPB1 T-cell epitope (TCE) mismatching algorithm and rs9277534 SNP at the 3' untranslated region (3'UTR) in the HLA-DPB1 gene are key factors for transplant-related events in unrelated hematopoietic cell transplantation (UR-HCT). However, the association of these 2 mechanisms has not been elucidated. We analyzed 19 frequent HLA-DPB1 alleles derived from Japanese healthy subjects by next-generation sequencing of the entire HLA-DPB1 gene region and multi-SNP data of the HLA region in 1589 UR-HCT pairs. The risk of acute graft-versus-host disease (aGVHD) was analyzed in 1286 patients with single HLA-DPB1 mismatch UR-HCT. The phylogenetic tree constructed using the entire gene region demonstrated that HLA-DPB1 alleles were divided into 2 groups, HLA-DP2 and HLA-DP5. Although a phylogenetic relationship in the genomic region from exon 3 to 3'UTR (Ex3-3'UTR) obviously supported the division of HLA-DP2 and HLA-DP5 groups, which in exon 2 showed intermingling of HLA-DPB1 alleles in a non-HLA-DP2 and non-HLA-DP5-group manner. Multi-SNP data also showed 2 discriminative HLA-DPB1 groups according to Ex3-3'UTR. Risk of grade 2-4 aGVHD was significantly higher in patient HLA-DP5 group mismatch than patient HLA-DP2 group mismatch (hazard ratio, 1.28; P = .005), regardless of donor mismatch HLA-DP group. Regarding TCE mismatch, increasing risk of aGVHD in patient HLA-DP5 group mismatch and TCE-nonpermissive mismatch were observed only in patients with TCE-permissive mismatch and patient HLA-DP2 group mismatch, respectively. Evolutionary analysis revealed that rs9277534 represented a highly conserved HLA-DPB1 Ex3-3'UTR region and may provoke aGVHD differently to TCE mismatching algorithm, reflecting exon 2 polymorphisms. These findings enrich our understanding of the mechanism of aGVHD in HLA-DPB1 mismatch UR-HCT.
© 2018 by The American Society of Hematology.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29246901      PMCID: PMC5824334          DOI: 10.1182/blood-2017-08-801449

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  28 in total

Review 1.  Estimation of failure probabilities in the presence of competing risks: new representations of old estimators.

Authors:  T A Gooley; W Leisenring; J Crowley; B E Storer
Journal:  Stat Med       Date:  1999-03-30       Impact factor: 2.373

2.  Immunogenetics of HLA-DP--A New View of Permissible Mismatches.

Authors:  Katharina Fleischhauer
Journal:  N Engl J Med       Date:  2015-08-13       Impact factor: 91.245

3.  Impact of highly conserved HLA haplotype on acute graft-versus-host disease.

Authors:  Satoko Morishima; Seishi Ogawa; Aiko Matsubara; Takakazu Kawase; Yasuhito Nannya; Koichi Kashiwase; Masahiro Satake; Hiroo Saji; Hidetoshi Inoko; Shunichi Kato; Yoshihisa Kodera; Takehiko Sasazuki; Yasuo Morishima
Journal:  Blood       Date:  2010-03-24       Impact factor: 22.113

4.  Structural basis for the specific recognition of the major antigenic peptide from the Japanese cedar pollen allergen Cry j 1 by HLA-DP5.

Authors:  Seisuke Kusano; Mutsuko Kukimoto-Niino; Yoko Satta; Noboru Ohsawa; Tomomi Uchikubo-Kamo; Motoaki Wakiyama; Mariko Ikeda; Takaho Terada; Ken Yamamoto; Yasuharu Nishimura; Mikako Shirouzu; Takehiko Sasazuki; Shigeyuki Yokoyama
Journal:  J Mol Biol       Date:  2014-07-11       Impact factor: 5.469

5.  Genome-wide surveillance of mismatched alleles for graft-versus-host disease in stem cell transplantation.

Authors:  Aiko Sato-Otsubo; Yasuhito Nannya; Koichi Kashiwase; Makoto Onizuka; Fumihiro Azuma; Yoshiki Akatsuka; Yasuko Ogino; Masahiro Satake; Masashi Sanada; Shigeru Chiba; Hiroh Saji; Hidetoshi Inoko; Giulia C Kennedy; Ken Yamamoto; Satoko Morishima; Yasuo Morishima; Yoshihisa Kodera; Takehiko Sasazuki; Seishi Ogawa
Journal:  Blood       Date:  2015-10-02       Impact factor: 22.113

6.  Biological significance of HLA locus matching in unrelated donor bone marrow transplantation.

Authors:  Yasuo Morishima; Koichi Kashiwase; Keitaro Matsuo; Fumihiro Azuma; Satoko Morishima; Makoto Onizuka; Toshio Yabe; Makoto Murata; Noriko Doki; Tetsuya Eto; Takehiko Mori; Koichi Miyamura; Hiroshi Sao; Tatsuo Ichinohe; Hiroo Saji; Shunichi Kato; Yoshiko Atsuta; Keisei Kawa; Yoshihisa Kodera; Takehiko Sasazuki
Journal:  Blood       Date:  2014-12-17       Impact factor: 22.113

7.  Effect of matching of class I HLA alleles on clinical outcome after transplantation of hematopoietic stem cells from an unrelated donor. Japan Marrow Donor Program.

Authors:  T Sasazuki; T Juji; Y Morishima; N Kinukawa; H Kashiwabara; H Inoko; T Yoshida; A Kimura; T Akaza; N Kamikawaji; Y Kodera; F Takaku
Journal:  N Engl J Med       Date:  1998-10-22       Impact factor: 91.245

8.  High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation.

Authors:  Stephanie J Lee; John Klein; Michael Haagenson; Lee Ann Baxter-Lowe; Dennis L Confer; Mary Eapen; Marcelo Fernandez-Vina; Neal Flomenberg; Mary Horowitz; Carolyn K Hurley; Harriet Noreen; Machteld Oudshoorn; Effie Petersdorf; Michelle Setterholm; Stephen Spellman; Daniel Weisdorf; Thomas M Williams; Claudio Anasetti
Journal:  Blood       Date:  2007-09-04       Impact factor: 22.113

9.  Reduced-intensity conditioning regimen workshop: defining the dose spectrum. Report of a workshop convened by the center for international blood and marrow transplant research.

Authors:  Sergio Giralt; Karen Ballen; Douglas Rizzo; Andreas Bacigalupo; Mary Horowitz; Marcelo Pasquini; Brenda Sandmaier
Journal:  Biol Blood Marrow Transplant       Date:  2009-03       Impact factor: 5.742

10.  Evidence for a new segregant series of B cell antigens that are encoded in the HLA-D region and that stimulate secondary allogenic proliferative and cytotoxic responses.

Authors:  S Shaw; A H Johnson; G M Shearer
Journal:  J Exp Med       Date:  1980-09-01       Impact factor: 14.307

View more
  16 in total

1.  Resolving MiSeq-Generated Ambiguities in HLA-DPB1 Typing by Using the Oxford Nanopore Technology.

Authors:  Jamie L Duke; Timothy L Mosbruger; Deborah Ferriola; Nilesh Chitnis; Taishan Hu; Nikolaos Tairis; David J Margolis; Dimitri S Monos
Journal:  J Mol Diagn       Date:  2019-06-04       Impact factor: 5.568

2.  Comparative evaluation of biological human leukocyte antigen DPB1 mismatch models for survival and graft-versus-host disease prediction after unrelated donor hematopoietic cell transplantation.

Authors:  Francesca Lorentino; Nicoletta Sacchi; Elena Oldani; Valeria Miotti; Alessandra Picardi; Anna Maria Gallina; Pietro Crivello; Paolo Bernasconi; Riccardo Saccardi; Lucia Farina; Fabio Benedetti; Michela Cerno; Anna Grassi; Benedetto Bruno; Francesca Patriarca; Fabio Ciceri; Katharina Fleischhauer; Luca Vago; Francesca Bonifazi
Journal:  Haematologica       Date:  2019-08-30       Impact factor: 9.941

3.  Selection of matched unrelated donors moving forward: from HLA allele counting to functional matching.

Authors:  Katharina Fleischhauer
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2019-12-06

4.  Role of HLA-DP Expression in Graft-Versus-Host Disease After Unrelated Donor Transplantation.

Authors:  Effie W Petersdorf; Mats Bengtsson; Dianne De Santis; Valerie Dubois; Katharina Fleischhauer; Ted Gooley; Mary Horowitz; J Alejandro Madrigal; Mari Malkki; Caroline McKallor; Yasuo Morishima; Machteld Oudshoorn; Stephen R Spellman; Jean Villard; Phil Stevenson; Mary Carrington
Journal:  J Clin Oncol       Date:  2020-06-01       Impact factor: 44.544

Review 5.  The MHC in the era of next-generation sequencing: Implications for bridging structure with function.

Authors:  Effie W Petersdorf; Colm O'hUigin
Journal:  Hum Immunol       Date:  2018-10-12       Impact factor: 2.850

6.  In silico prediction of nonpermissive HLA-DPB1 mismatches in unrelated HCT by functional distance.

Authors:  Esteban Arrieta-Bolaños; Pietro Crivello; Bronwen E Shaw; Kwang Woo Ahn; Hai-Lin Wang; Michael R Verneris; Katharine C Hsu; Joseph Pidala; Stephanie J Lee; Katharina Fleischhauer; Stephen R Spellman
Journal:  Blood Adv       Date:  2018-07-24

7.  Cryopreserved Human Oocytes and Cord Blood Cells Can Produce Somatic Cell Nuclear Transfer-Derived Pluripotent Stem Cells with a Homozygous HLA Type.

Authors:  Jeoung Eun Lee; Ji Yoon Lee; Chang-Hwan Park; Jin Hee Eum; Soo Kyung Jung; A-Reum Han; Dong-Won Seol; Jin Saem Lee; Hyun Soo Shin; Jung Ho Im; Taehoon Chun; Kyungsoo Ha; Deok Rim Heo; Tae Ki Yoon; Dong Ryul Lee
Journal:  Stem Cell Reports       Date:  2020-06-04       Impact factor: 7.765

8.  Dissecting Genetic Control of HLA-DPB1 Expression and Its Relation to Structural Mismatch Models in Hematopoietic Stem Cell Transplantation.

Authors:  Thuja Meurer; Esteban Arrieta-Bolaños; Maximilian Metzing; Mona-May Langer; Peter van Balen; J H Frederik Falkenburg; Dietrich W Beelen; Peter A Horn; Katharina Fleischhauer; Pietro Crivello
Journal:  Front Immunol       Date:  2018-10-05       Impact factor: 7.561

9.  Reference Grade Characterization of Polymorphisms in Full-Length HLA Class I and II Genes With Short-Read Sequencing on the ION PGM System and Long-Reads Generated by Single Molecule, Real-Time Sequencing on the PacBio Platform.

Authors:  Shingo Suzuki; Swati Ranade; Ken Osaki; Sayaka Ito; Atsuko Shigenari; Yuko Ohnuki; Akira Oka; Anri Masuya; John Harting; Primo Baybayan; Miwako Kitazume; Junichi Sunaga; Satoko Morishima; Yasuo Morishima; Hidetoshi Inoko; Jerzy K Kulski; Takashi Shiina
Journal:  Front Immunol       Date:  2018-10-04       Impact factor: 7.561

10.  Association of human leukocyte antigens-DQB2/DPA1/DPB1 polymorphism and pulmonary tuberculosis in the Chinese Uygur population.

Authors:  Xue Wang; Xudong Cao; Wanjiang Zhang; Le Zhang; Lijun Lu; Xinyue Li; Saeed El-Ashram; Jiangdong Wu; Chuangfu Chen
Journal:  Mol Genet Genomic Med       Date:  2019-01-01       Impact factor: 2.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.